Cargando…
Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes
We aimed to identify metabolites to predict patients’ response to glucose lowering treatment during the first 5 years after detection of type 2 diabetes. Metabolites were measured by GC–MS in baseline samples from 346 screen-detected type 2 diabetes patients in the ADDITION-NL study. The response to...
Autores principales: | den Ouden, Henk, Pellis, Linette, Rutten, Guy E. H. M., Geerars-van Vonderen, Ilse K., Rubingh, Carina M., van Ommen, Ben, van Erk, Marjan J., Beulens, Joline W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703625/ https://www.ncbi.nlm.nih.gov/pubmed/26770180 http://dx.doi.org/10.1007/s11306-015-0930-4 |
Ejemplares similares
-
Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status
por: Pellis, Linette, et al.
Publicado: (2011) -
Controlling false discovery rates in factorial experiments with between-subjects and within-subjects tests
por: Schoen, Eric D, et al.
Publicado: (2013) -
Metabolic Profiling of the Response to an Oral Glucose Tolerance Test Detects Subtle Metabolic Changes
por: Wopereis, Suzan, et al.
Publicado: (2009) -
Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study
por: van Erk, Marjan J, et al.
Publicado: (2010) -
Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge
por: Wopereis, Suzan, et al.
Publicado: (2017)